• Citer

Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study.

par Jilek, Samantha;Jaquiéry, Emilie;Hirsch, Hans H;Lysandropoulos, Andreas ;Canales, Mathieu;Guignard, Laurence;Schluep, Myriam;Pantaleo, Giuseppe;Du Pasquier, Renaud A
Référence Lancet neurology, 9, 3, page (264-272)
Publication Publié, 2010-03

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study.
Auteur:	Jilek, Samantha; Jaquiéry, Emilie; Hirsch, Hans H; Lysandropoulos, Andreas; Canales, Mathieu; Guignard, Laurence; Schluep, Myriam; Pantaleo, Giuseppe; Du Pasquier, Renaud A
Informations sur la publication:	Lancet neurology, 9, 3, page (264-272)
Statut de publication:	Publié, 2010-03
Sujet CREF:	Neurologie
MeSH keywords:	Adult
	Antibodies, Monoclonal -- adverse effects -- therapeutic use
	Antibodies, Monoclonal, Humanized
	CD4-Positive T-Lymphocytes -- immunology -- virology
	CD8-Positive T-Lymphocytes -- immunology -- virology
	Cross-Sectional Studies
	Female
	Humans
	Immunity, Cellular -- immunology
	JC Virus -- immunology
	Leukoencephalopathy, Progressive Multifocal -- chemically induced -- immunology -- virology
	Longitudinal Studies
	Lymphocyte Activation -- immunology
	Male
	Multiple Sclerosis -- drug therapy -- immunology -- virology
	Prospective Studies
Note générale:	Comparative Study
	Journal Article
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:1474-4422
	info:doi/10.1016/S1474-4422(10)70006-5
	info:pii/S1474-4422(10)70006-5
	info:pmid/20117055